Differential haplotypic expression of the interleukin-18 gene

European Journal of Human Genetics

Volumn 15, Issue 8, 2007, Pages 856-863

  Barbaux, Sandrine ^a,c   Poirier, Odette ^a,c   Godefroy, Tiphaine ^a,c   Kleinert, Hartmut ^b   Blankenberg, Stefan ^b   Cambien, François ^a,c   Tiret, Laurence ^a,c  

^a INSERM   (France)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 18; MESSENGER RNA;

3' UNTRANSLATED REGION; ALLELE; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC TRANSFECTION; GENOTYPE; HAPLOTYPE; HETEROZYGOSITY; HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA DEGRADATION;

CARDIOVASCULAR DISEASES; GENE EXPRESSION REGULATION; HAPLOTYPES; HUMANS; INTERLEUKIN-18; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES;

EID: 34547172668     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/sj.ejhg.5201842     Document Type: Article

References (32)

1. Dinarello CA: Interleukin-18. Methods 1999; 19: 121-132.
2. McInnes IBA Gracie JA, Leung BP,Wei XQ, Liew FY: Interleukin 18: a pleiotropic participant in chronic inflammation. Immunol Today 2000; 21: 312-315.
3. Netea MG, Joosten LA, Lewis E et al: Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance. Nat Med 2006; 12: 650-656.
4. Caligiuri G, Kaveri S, Nicoletti A: When interleukin-18 conducts, the Preludio sounds the same no matter who plays. Arterioscler Thromb Vasc Biol 2005; 25: 655-657.
5. Mallat Z, Corbaz A, Scoazec A et al: Interleukin-18/interleukin-18 binding protein signaling modulates atherosclerotic lesion development and stability. Circ Res 2001; 89: E41-E45.
6. Whitman SC, Ravisankar P, Daugherty A: Interleukin-18 enhances atherosclerosis in apolipoprotein E(-/-) mice through release of interferon-gamma. Circ Res 2002; 90: E34-38.
7. Elhage R, Jawien J, Rudling M et al: Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice. Cardiovasc Res 2003; 59: 234-240.
8. de Nooijer R, von der Thusen JH, Verkleij CJ et al: Overexpression of IL-18 decreases intimal collagen content and promotes a vulnerable plaque phenotype in apolipoprotein-E-deficient mice. Arterioscler Thromb Vasc Biol 2004; 24: 2313-2319.
9. Mallat Z, Silvestre JS, Le Ricousse-Roussanne S et al: Interleukin-18/interleukin-18 binding protein signaling modulates ischemia-induced neovascularization in mice hindlimb. Circ Res 2002; 91: 441-448.
10. Maffia P, Grassia G, Di Meglio P et al: Neutralization of interleukin-18 inhibits neointimal formation in a rat model of vascular injury. Circulation 2006; 114: 430-437.
11. Mallat Z, Corbaz A, Scoazec A et al: Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability. Circulation 2001; 104: 1598-1603.
12. Gerdes N, Sukhova GK, Libby P, Reynolds RS, Young JL, Schonbeck U: Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for atherogenesis. J Exp Med 2002; 195: 245-257.
13. Blankenberg S, Tiret L, Bickel C et al: Interleukin 18 is a strong predictor of cardiovascular death in stable and unstable angina. Circulation 2002; 106: 24-30.
14. Blankenberg S, Luc G, Ducimetière P et al: Interleukin-18 and the risk of coronary heart disease in European men: The Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation 2003; 108: 2453-2459.
15. Koenig W, Khuseyinova N, Baumert J et al: Increased concentrations of C-reactive protein and IL-6 but not IL-18 are independently associated with incident coronary events in middle-aged men and women: results from the MONICA/KORA Augsburg case - cohort study, 1984-2002. Arterioscler Thromb Vasc Biol 2006; 26: 2745-2751.
16. Giedraitis V, He B, Huang WX, Hillert J: Cloning and mutation analysis of the human IL-18 promoter: A possible role of polymorphisms in expression regulation. J Neuroimmunol 2001; 112: 146-152.
17. Tiret L, Godefroy T, Lubos E et al: Genetic analysis of the interleukin-18 system highlights the role of the interleukin-18 gene in cardiovascular disease. Circulation 2005; 112: 643-650.
18. Parra HJ, Arveiler D, Evans AE et al: A case-control study of lipoprotein particles in two populations at contrasting risk for coronary heart disease. The ECTIM Study. Arterioscler Thromb 1992; 12: 701-707.
19. Liljedahl U, Fredriksson M, Dahlgren A, Syvanen AC: Detecting imbalanced expression of SNP alleles by minisequencing on microarrays. BMC Biotechnol 2004; 4: 24.
20. Yan H, Dobbie Z, Gruber SB et al: Small changes in expression affect predisposition to tumorigenesis. Nat Genet 2002; 30: 25-26.
21. Lo HS, Wang Z, Hu Y et al: Allelic variation in gene expression is common in the human genome. Genome Res 2003; 13: 1855-1862.
22. Pastinen T, Sladek R, Gurd S et al: A survey of genetic and epigenetic variation affecting human gene expression. Physiol Genomics 2004; 16: 184-193.
23. Heighway J, Bowers NL, Smith S, Betticher DC, Koref MF: The use of allelic expression differences to ascertain functional polymorphisms acting in cis: Analysis of MMP1 transcripts in normal lung tissue. Ann Hum Genet 2005; 69: 127-133.
24. Blankenberg S, Godefroy T, Poirier O et al: Haplotypes of the caspase-1 gene, plasma caspase-1 levels, and cardiovascular risk. Circ Res 2006; 99: 102-108.
25. Clop A, Marcq F, Takeda H et al: A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep. Nat Genet 2006; 38: 813-818.
26. Satwani P, Ayello J, Ven C et al: Immaturity of IL-18 gene expression and protein production in cord blood (CB) versus peripheral blood (PB) mononuclear cells and differential effects in natural killer (NK) cell development and function. Br J Haematol 2005; 130: 284-292.
27. Bufler P, Gamboni-Robertson F, Azam T, Kim SH, Dinarello CA: Interleukin-1 homologues IL-1F7b and IL-18 contain functional mRNA instability elements within the coding region responsive to lipopolysaccharide. Biochem J 2004; 381: 503-510.
28. Zhou Y, Yamaguchi E, Hizawa N, Nishimura M: Roles of functional polymorphisms in the interleukin-18 gene promoter in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2005; 22: 105-113.
29. Liang XH, Cheung W, Heng CK, Wang DY: Reduced transcriptional activity in individuals with IL-18 gene variants detected from functional but not association study. Biochem Biophys Res Commun 2005; 338: 736-741.
30. Sugiura T, Maeno N, Kawaguchi Y et al: A promoter haplotype of the interleukin-18 gene is associated with juvenile idiopathic arthritis in the Japanese population. Arthritis Res Ther 2006; 8: R60.
31. Arimitsu J, Hirano T, Higa S et al: IL-18 gene polymorphisms affect IL-18 production capability by monocytes. Biochem Biophys Res Commun 2006; 342: 1413-1416.
32. Forton JT, Udalova IA, Campino S, Rockett KA, Hull J, Kwiatkowski DP: Localization of a long-range cis-regulatory element of IL13 by allelic transcript ratio mapping. Genome Res 2007; 17: 82-87.